Cornea/External Disease News

A 92-year-old Asian man was seen in the uveitis ophthalmology clinic due to 2 weeks of bilateral eye injection, pain, tearing and photosensitivity. He denied flashes, floaters, diplopia or metamorphopsia.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

It is autumn on the North Coast. Longer nights lead to deeper insights as we contemplate the winter solstice. As usual, I am thinking dry eye. It is, as they say, how I roll.

CHICAGO — Many diseases can present as dry eye, leading to missed diagnoses and failed treatment, according to a speaker here.

CHICAGO — In this Healio Video Perspective from the AAO meeting, William B. Trattler, MD, discusses a study that evaluated age and keratoconus progression.

Okyo Pharma has announced that screening and recruitment has been initiated for a phase 2 trial of OK-101 to treat neuropathic corneal pain, with plans to enroll 48 patients, according to a company press release.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Lisa K. Feulner, MD, PhD, explains why surgeons must treat the ocular surface before refractive cataract surgery and shares her algorithm for management.

CHICAGO — Valacyclovir can be beneficial for treating multiple episodes of keratitis or iritis in patients with herpes zoster ophthalmicus, according to a speaker here.

CHICAGO — Patients treated with mirvetuximab require close follow-up with an ophthalmologist due to the potential for corneal toxicity, according to a study.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Rob Sambursky, MD, president of Verséa Ophthalmics, discusses the company’s offerings for ocular wound healing and ocular surface diseases.